ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.720,01
-1,47%
S&P 500
5.702,55
-0,19%
Dow Jones
42.063,36
0,09%
Euro vs US Dollar
1,11705
-0,04%
Bitcoin
63.159,92
-0,07%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Castle Biosciences Inc (CSTL)

  7. Castle Biosciences Inc (CSTL) News

CSTL

Castle Biosciences (CSTL)

Castle Biosciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CSTL
DatumZeitQuelleÜberschriftSymbolFirma
16/09/202413h00Business WireCastle Biosciences’ Chief Operating Officer Kristen Oelschlager Named Arizona Bioscience Leader of the YearNASDAQ:CSTLCastle Biosciences Inc
11/09/202413h00Business WireDecisionDx®-Melanoma Can Identify Melanoma Patients with Low Risk of Sentinel Lymph Node Positivity Who May Safely Forego Biopsy Surgery, New Independent Study AffirmsNASDAQ:CSTLCastle Biosciences Inc
05/09/202422h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
05/09/202413h00Business WireStudy Confirms the Ability of Castle Biosciences' DecisionDx®-SCC Test to Predict Likelihood of Benefit from Adjuvant Radiation Therapy in Patients with High-Risk Cutaneous Squamous Cell CarcinomaNASDAQ:CSTLCastle Biosciences Inc
28/08/202413h00Business WireCastle Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:CSTLCastle Biosciences Inc
14/08/202400h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
14/08/202400h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
14/08/202400h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
14/08/202400h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
05/08/202422h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
05/08/202422h10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CSTLCastle Biosciences Inc
05/08/202422h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CSTLCastle Biosciences Inc
05/08/202422h05Business WireCastle Biosciences Reports Second Quarter 2024 ResultsNASDAQ:CSTLCastle Biosciences Inc
02/08/202421h13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CSTLCastle Biosciences Inc
31/07/202422h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
30/07/202413h00Business WireCastle Biosciences to Present at the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:CSTLCastle Biosciences Inc
22/07/202413h00Business WireCastle Biosciences and Skin Cancer Survivor Teddi Mellencamp Arroyave Launch Campaign to Increase Awareness of MelanomaNASDAQ:CSTLCastle Biosciences Inc
16/07/202422h51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
16/07/202422h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
15/07/202413h00Business WireCastle Biosciences to Release Second Quarter 2024 Financial Results and Host Conference Call on Monday, Aug. 5, 2024NASDAQ:CSTLCastle Biosciences Inc
11/07/202413h00Business WireCastle Biosciences Honored with Top Workplaces AwardsNASDAQ:CSTLCastle Biosciences Inc
24/06/202413h00Business WireRecent AGA Clinical Practice Guideline Acknowledges That Individuals Who May Be at Increased Risk of Progression to Esophageal Cancer Might Be Identified Using Tissue-Based Biomarkers, Particularly Castle Biosciences’ TissueCypher® TestNASDAQ:CSTLCastle Biosciences Inc
20/06/202413h00Business WireCastle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CSTLCastle Biosciences Inc
14/06/202422h30Business WireCastle Biosciences’ Founder, President and CEO Derek Maetzold Named an EY Entrepreneur Of The Year® 2024 Gulf South Award WinnerNASDAQ:CSTLCastle Biosciences Inc
05/06/202400h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
30/05/202422h30Business WireCastle Biosciences to Present New Data at 2024 ASCO® Annual Meeting Highlighting Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Metastasis to the Central Nervous System to Prompt Use of Imaging SurveillanceNASDAQ:CSTLCastle Biosciences Inc
29/05/202422h44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
29/05/202422h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
29/05/202422h30Business WireNew Publication Shows DecisionDx®-SCC Identifies High-Risk Squamous Cell Carcinoma Patients Who Are Likely to Benefit from Adjuvant Radiation Therapy and Those Who Can Consider Deferring Treatment Based on Biological Risk of MetastasisNASDAQ:CSTLCastle Biosciences Inc
28/05/202422h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CSTL

Kürzlich von Ihnen besucht

AMEX
SPY
SPDR S&P 500
TG
BAS
BASF
NYSE
MRK
Merck
CCOM
SILVER
SILVER
CCOM
US500
US 500
DBI
SDXP
SDAX
AMEX
XLV
Health Care Select Sector
TG
ALV
Allianz
DBI
MDAX
MDAX
USOTC
RHHBY
Roche (QX)
NYSE
MCD
McDonalds
TG
DBK
Deutsche Bank
NASDAQ
TSLA
Tesla
NASDAQ
GOOGL
Alphabet
FX
EURUSD
Euro vs US Dollar
USOTC
ADDYY
Adidas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten